欢迎使用我们的服务！
限时优惠，立即购买享受折扣
24小时客服在线，随时为您服务
优质产品，值得信赖

印度仿制药专卖店
登录
顶 置

文章列表

Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease

2026-07-02
Nippon Shinyaku Options New DMD Asset Amid Capricor Legal Spat

2026-07-02
What does practical sustainability in API manufacturing really look like?

2026-07-02
R1 Therapeutics forms advisory board to support advancement of AP306

2026-07-02
EU CHMP Opinions And MAA Updates

2026-07-02
Scrip’s Guide To The Month Ahead: July 2026

2026-07-01
Cross-agency targeted campaign "Peptides 2026"

2026-07-01
Sandoz Starts Generic Tirzepatide Race With FDA Filing Acceptance

2026-07-01
WHO urges scale up of newborn screening to improve early detection and care of birth defects

2026-07-01
Pipeline Watch: Japan Dominates Thirty-Four Approvals Plus Seven Phase III Readouts

2026-07-01
US FDA’s Biologics Center Losing Acting Gene Therapy Office Director

2026-06-30
Smaller European Countries Call For Deeper Collaboration On Pricing And Reimbursement

2026-06-30